• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem No Code Available (3191)
Event Date 12/05/2016
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing records for the devices could not be conducted because the lot numbers remain unknown.Further information was requested and will be provided.Please note that the article ¿peripheral stent thrombosis leading to acute limb ischemia and major amputation: incidence and risk factors in the aortoiliac and femoropopliteal arteries ¿ (cardiovasc intervent radiol p.351¿359, konstantinos katsanos, said a.M.Al-lamki, aneeta parthipun, stavros spiliopoulos, sanjay dhanji patel, ioannis paraskevopoulos, hany zayed and athanasios diamantopoulo).The date of publication was used as the date of incident.
 
Event Description
In review of published literature, these findings were noted.In a literature article titled ¿peripheral stent thrombosis leading to acute limb ischemia and major amputation: incidence and risk factors in the aortoiliac and femoropopliteal arteries ¿ (cardiovasc intervent radiol p.351¿359, konstantinos katsanos, said a.M.Al-lamki, aneeta parthipun, stavros spiliopoulos, sanjay dhanji patel, ioannis paraskevopoulos, hany zayed and athanasios diamantopoulo) it states from 2009 to 2014, 256 patients (n=277 limbs) were analyzed over a 5 year period.Gore® viabahn® endoprostheses were utilized as well as gore® tigris® vascular stents.In the article was discussed that within the setting of acute stent thrombosis and acute limb ischemia (ali) presentation, four major amputations occurred within the first 2 months.The major amputation rate for gore® viabahn® endoprosthesis was 8.7%.The majority of the patients were treated due to chronic atherosclerotic disease (96%).
 
Manufacturer Narrative
Further information was requested and was not available.According to the gore® viabahn® endoprosthesis instructions for use (ifu), complications and adverse events can occur include, but are not limited to thrombosis or occlusion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
nataliya baramzina
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6749020
MDR Text Key81230398
Report Number2017233-2017-00386
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/27/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received08/22/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age74 YR
-
-